BRYAN MAZLISH

Co-Founder, Executive Board Director

Before founding Bigfoot, Bryan previously led a successful career in quantitative finance, first as management in one of the world’s largest securities trading institutions, and subsequently as an entrepreneur, where he founded and led a fully automated trading company. Since his son’s diagnosis with T1D in 2011, Bryan has focused his efforts in the diabetes technology space where he invented algorithms for predicting glucose values and automating insulin delivery. His wife and son, both of whom have T1D, have benefited over the past four years from the use of a proof of concept device that he created to automate their insulin delivery. This is the first real-world demonstration of successful use of adaptive insulin delivery algorithms in pediatric and adult settings over an extended period of time.

“For the four years that my family has used the first system I created, diabetes has been so much easier to manage that it's like a different disease."

IAN HANSON

Chief Operating Officer

Ian has 20 years of experience in device development with particular expert proficiency in drug delivery systems. He comes most recently from Unilife, where he served as Senior Vice President and Chief Operating Officer and led the development of their wearable injector platform and advanced drug delivery systems. Prior to Unilife, Hanson held senior leadership roles with Medtronic Diabetes where he created their Advanced and Systems Engineering Department and was responsible for development and commercialization of insulin delivery devices and diabetes management systems for over a decade. Through his almost 11 years with Medtronic, he gained exceptional product development acumen, especially with respect to the rigor required of regulated technologies.

Dr. Jim Malone

Chief Medical Officer

Dr. Malone is a diabetologist with 12 years in clinical practice and more than 20 years in clinical research at Eli Lilly & Company, where he developed diabetes products and delivery devices. At Bigfoot Biomedical, he leads the clinical and medical affairs teams and is an integral part of shaping the company’s holistic approach to managing diabetes care to lessen the burden for both patients and health care providers. Dr. Malone has been a long-time volunteer for the American Diabetes Association, where he served as President of the Indiana Affiliate, and was on the ADA diabetes camp medical staff for 25 years. He also volunteers for JDRF, serving on the Board of Directors for the Indiana Affiliate and is past president of the Indiana Board.

MATT RAINVILLE

Chief Commerical Officer

Matt is a commercial executive in the pharmaceutical and medical technology industry with more than two decades of leadership experience. He has extensive experience in sales, operations, and marketing strategies in the global diabetes market. Matt previously served as Insulet Corporation’s vice president and general manager of global Type 2 diabetes markets, where he led the company’s Omnipod Type 2 franchise and helped to expand access to insulin pumps for people with diabetes. Prior to Insulet, Matt spent 13 years with Eli Lilly and Company, where he held integral leadership roles in sales, training and development, marketing, operations, and market access – contributing to the successful launch of nine diabetes products globally. He has a BS in Marketing from the University of Connecticut and completed the HBX Core Program through Harvard Business School.

KATE LEE

SVP, Regulatory & Quality

Kate brings more than 25 years experience in medical device development and is responsible for the Regulatory, Quality and Human Factors functions at Bigfoot. Most recently Kate provided regulatory and quality consulting to companies in the cardiovascular and diabetes spaces. Prior to leaving consulting to join Bigfoot, Kate held a variety of leadership roles in regulatory, quality and product development, establishing a robust understanding of the regulated medical device space. At Hansen Medical, she served in roles with increasing responsibilities and was in charge of all regulatory activities, encompassing US and OUS submissions and post-market surveillance. Kate spent the first part of her career in R&D, developing and later leading teams in the development of innovative devices in the cardiovascular, vascular and gastroenterology specialties. Kate earned a Master’s degree in Smart Product Design from Stanford and a Bachelor’s degree in Mechanical Engineering from Harvard.

GEOFF SHIPSIDES

General Counsel

Geoff has served as Bigfoot's General Counsel since March 2019. From 2015 to 2019, he served as Bigfoot's Vice President, Intellectual Property. During his time at Bigfoot, Geoff was responsible for building the Company’s legal structure and compliance framework, as well as advising on strategic transactions. Geoff's strong background in intellectual property has assisted Bigfoot in developing a patent portfolio that includes over 600 patent assets.  Prior to joining Bigfoot, Geoff was a Principal at Fish & Richardson PC, where he focused on advising innovative medical device and consumer product companies.  Geoff earned a Bachelor of Science in Chemical Engineering from the University of Florida and his Juris Doctorate from Georgetown University Law Center. Prior to law school, Geoff worked as a Patent Examiner for the United States Patent and Trademark Office.